Compare Cytokinetics Inc (CYTK) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Vanguard Real Estate Index Fund ETF — how do they compare? Cytokinetics Inc trades at $62.91 (market cap $8.62B), while Vanguard Real Estate Index Fund ETF trades at $90.65 (market cap $70.80B). The key difference: Vanguard Real Estate Index Fund ETF is far larger — about 8.2× Cytokinetics Inc's market cap, and Vanguard Real Estate Index Fund ETF is more actively traded (6,073,580 versus 2,594,626). Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and Vanguard Real Estate Index Fund ETF for 113 Days on average.
| CYTK | VNQ | |
|---|---|---|
Market Cap | $8.62B | $70.80B |
Volume | 2,594,626 | 6,073,580 |
Sector | Health | — |
52-Week High | $87.26 | $100.95 |
52-Week Low | $54.76 | $87.00 |
Typical Hold Time | 19 Days | 113 Days |
Enterprise Value | $8.72B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CYTK trades at $62.01, up 1.46% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported Q2 2026 EPS of -$1.50, beating expectations, but maintains deeply negative profitability with a net income margin of -1,321.12% for 2026. Recent news highlights clinical progress for aficamten in hypertrophic cardiomyopathy studies and presentations at major medical conferences.
Wall Street sentiment is overwhelmingly bullish with a 97.14% buy rating and a $112.60 consensus price target, signaling strong upside potential. However, high cash burn, substantial losses, and significant debt-to-asset ratio of 81.23% present substantial financial risks. Investment appeal hinges on successful commercialization of its pipeline amid intense competition.
VNQ trades at $89.35, up 0.74% today, but faces bearish technical signals with moving averages indicating selling pressure. The ETF has declined nearly 10% recently amid rising Treasury yields and Fed rate hikes, eroding its income appeal versus safer alternatives. Recent institutional buying by State Street Corp and Envestnet suggests some see value at current levels, while news highlights sector headwinds from interest rate sensitivity and oversupply concerns in certain real estate segments.
Outlook remains challenged by rising rates compressing REIT valuations, though contrarian investors see opportunity in discounted sector exposure. Key risks include prolonged high interest rates, economic slowdown impacting property demand, and competition from Treasury yields. The dividend yield advantage has narrowed significantly, requiring careful assessment of total return potential versus rate-sensitive alternatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →
